CERS vs CVS · rev $201.3M vs P/E 16, rev $402.07B
Cerus Corporation (CERS) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.
Cerus Corporation (CERS) is a medical devices company listed on US.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Latest reported CERS revenue for 2024-12-31 was $201.3M. Net income was -$21.0M. Revenue was up 7.8% from 2023-12-31 to 2024-12-31. CERS currently screens at market cap $294.4M.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
CERS currently screens at market cap $294.4M. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Not investment advice. Open the CERS and CVS stock pages for the full models.
Not investment advice.